These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28096082)
1. The ties that bind. Lundh A; Bero L BMJ; 2017 Jan; 356():j176. PubMed ID: 28096082 [No Abstract] [Full Text] [Related]
2. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
3. Note from the editor. Freedman R Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255 [No Abstract] [Full Text] [Related]
4. Medical ethics, research and the pharmaceutical industry. Abud-Mendoza C Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694 [No Abstract] [Full Text] [Related]
5. The perverse consequences of a proposed global tax on research. MacDonald C; Walton N Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972 [No Abstract] [Full Text] [Related]
6. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine. Steinbrook R; Redberg RF JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117 [No Abstract] [Full Text] [Related]
7. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
8. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials. Roehr B BMJ; 2012 May; 344():e3767. PubMed ID: 22641830 [No Abstract] [Full Text] [Related]
9. Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study. Jones CW; Misemer BS; Platts-Mills TF; Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Keyhani S BMJ Open; 2018 Feb; 8(2):e019831. PubMed ID: 29439079 [TBL] [Abstract][Full Text] [Related]
10. [The difficult relationship of industry and science. Money versus research]. Wessling A Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617 [No Abstract] [Full Text] [Related]
13. Regulating the market in human research participants. Lemmens T; Miller PB PLoS Med; 2006 Aug; 3(8):e330. PubMed ID: 16866575 [TBL] [Abstract][Full Text] [Related]
14. Research in the physician's office: navigating the ethical minefield. Snyder L; Mueller PS Hastings Cent Rep; 2008; 38(2):23-5. PubMed ID: 18457224 [No Abstract] [Full Text] [Related]
15. Biased articles. Friedman JH Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378 [No Abstract] [Full Text] [Related]
16. Ethical issues in the relationships involving medicine and industry. Thomas PS; Tan KS; Yates DH Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554 [No Abstract] [Full Text] [Related]
17. Minimizing bias in industry-sponsored outcomes research. Freeman RA Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357 [TBL] [Abstract][Full Text] [Related]
18. Industry sponsored research. Klotz LH Can J Urol; 2004 Aug; 11(4):2312-3. PubMed ID: 15380051 [No Abstract] [Full Text] [Related]
19. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
20. [Economic benefit and ethical challenges]. Riska O Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1990. PubMed ID: 18800394 [No Abstract] [Full Text] [Related] [Next] [New Search]